Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,882,613
-$7,457,000 QoQ
Shares Held
2,191,843
+14.1% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. CRMD ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in CRMD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,882,613 | 2,191,843 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,339,613 | 1,920,861 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $21,348,272 | 1,835,621 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $19,732,303 | 1,601,648 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,480,997 | 1,539,123 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,770,498 | 1,453,148 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,904,108 | 1,225,756 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,263,340 | 1,215,552 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,705,797 | 1,109,858 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,034,983 | 1,073,134 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,260,288 | 881,159 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,228,880 | 813,320 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $482,880 | 170,629 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $775,751 | 192,973 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,764,064 | 686,873 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,193,290 | 701,822 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,238,794 | 696,515 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,326,286 | 630,654 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,659,443 | 666,611 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $4,055,338 | 545,806 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,039,994 | 504,145 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $3,012,811 | 478,224 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,634,444 | 455,277 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||